BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36758443)

  • 1. Mixture risk assessment and human biomonitoring: Lessons learnt from HBM4EU.
    Luijten M; Vlaanderen J; Kortenkamp A; Antignac JP; Barouki R; Bil W; van den Brand A; den Braver-Sewradj S; van Klaveren J; Mengelers M; Ottenbros I; Rantakokko P; Kolossa-Gehring M; Lebret E
    Int J Hyg Environ Health; 2023 Apr; 249():114135. PubMed ID: 36758443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of human biomonitoring data to support policy development, raise awareness and environmental public health protection among countries within the HBM4EU project.
    Ubong D; Stewart L; Sepai O; Knudsen LE; Berman T; Reynders H; Van Campenhout K; Katsonouri A; Van Nieuwenhuyse A; Ingelido AM; Castaño A; Pedraza-Díaz S; Eiríksdóttir ÁV; Thomsen C; Hartmann C; Gjorgjev D; De Felip E; Tolonen H; Santonen T; Klanova J; Norström K; Kononenko L; Silva MJ; Uhl M; Kolossa-Gehring M; Apel P; Jõemaa M; Jajcaj M; Estokova M; Luijten M; Lebret E; von Goetz N; Holcer NJ; Probst-Hensch N; Cavaleiro R; Barouki R; Tarroja E; Balčienė RM; Strumylaite L; Latvala S; Namorado S; Szigeti T; Ingi Halldorsson T; Olafsdottir K; Wasowicz W;
    Int J Hyg Environ Health; 2023 Jun; 251():114170. PubMed ID: 37207539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment.
    Apel P; Rousselle C; Lange R; Sissoko F; Kolossa-Gehring M; Ougier E
    Int J Hyg Environ Health; 2020 Sep; 230():113622. PubMed ID: 33045523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
    Louro H; Heinälä M; Bessems J; Buekers J; Vermeire T; Woutersen M; van Engelen J; Borges T; Rousselle C; Ougier E; Alvito P; Martins C; Assunção R; Silva MJ; Pronk A; Schaddelee-Scholten B; Del Carmen Gonzalez M; de Alba M; Castaño A; Viegas S; Humar-Juric T; Kononenko L; Lampen A; Vinggaard AM; Schoeters G; Kolossa-Gehring M; Santonen T
    Int J Hyg Environ Health; 2019 Jun; 222(5):727-737. PubMed ID: 31176761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU.
    Santonen T; Mahiout S; Alvito P; Apel P; Bessems J; Bil W; Borges T; Bose-O'Reilly S; Buekers J; Cañas Portilla AI; Calvo AC; de Alba González M; Domínguez-Morueco N; López ME; Falnoga I; Gerofke A; Caballero MDCG; Horvat M; Huuskonen P; Kadikis N; Kolossa-Gehring M; Lange R; Louro H; Martins C; Meslin M; Niemann L; Díaz SP; Plichta V; Porras SP; Rousselle C; Scholten B; Silva MJ; Šlejkovec Z; Tratnik JS; Joksić AŠ; Tarazona JV; Uhl M; Van Nieuwenhuyse A; Viegas S; Vinggaard AM; Woutersen M; Schoeters G
    Int J Hyg Environ Health; 2023 Apr; 249():114139. PubMed ID: 36870229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population.
    Buekers J; David M; Koppen G; Bessems J; Scheringer M; Lebret E; Sarigiannis D; Kolossa-Gehring M; Berglund M; Schoeters G; Trier X
    Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phthalates and substitute plasticizers: Main achievements from the European human biomonitoring initiative HBM4EU.
    Gerofke A; Lange R; Vogel N; Schmidt P; Weber T; David M; Frederiksen H; Baken K; Govarts E; Gilles L; Martin LR; Martinsone Ž; Santonen T; Schoeters G; Scheringer M; Domínguez-Romero E; López ME; Calvo AC; Koch HM; Apel P; Kolossa-Gehring M
    Int J Hyg Environ Health; 2024 Jun; 259():114378. PubMed ID: 38631089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBM4EU results support the Chemicals' Strategy for Sustainability and the Zero-Pollution Action Plan.
    Lobo Vicente J; Ganzleben C; Gasol R; Marnane I; Gilles L; Buekers J; Bessems J; Colles A; Gerofke A; David M; Barouki R; Uhl M; Sepai O; Loots I; Crabbé A; Coertjens D; Kolossa-Gehring M; Schoeters G
    Int J Hyg Environ Health; 2023 Mar; 248():114111. PubMed ID: 36706581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants.
    Gilles L; Govarts E; Rodriguez Martin L; Andersson AM; Appenzeller BMR; Barbone F; Castaño A; Coertjens D; Den Hond E; Dzhedzheia V; Eržen I; López ME; Fábelová L; Fillol C; Franken C; Frederiksen H; Gabriel C; Haug LS; Horvat M; Halldórsson TI; Janasik B; Holcer NJ; Kakucs R; Karakitsios S; Katsonouri A; Klánová J; Kold-Jensen T; Kolossa-Gehring M; Konstantinou C; Koponen J; Lignell S; Lindroos AK; Makris KC; Mazej D; Morrens B; Murínová ĽP; Namorado S; Pedraza-Diaz S; Peisker J; Probst-Hensch N; Rambaud L; Rosolen V; Rucic E; Rüther M; Sarigiannis D; Tratnik JS; Standaert A; Stewart L; Szigeti T; Thomsen C; Tolonen H; Eiríksdóttir Á; Van Nieuwenhuyse A; Verheyen VJ; Vlaanderen J; Vogel N; Wasowicz W; Weber T; Zock JP; Sepai O; Schoeters G
    Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a systematic use of effect biomarkers in population and occupational biomonitoring.
    Zare Jeddi M; Hopf NB; Viegas S; Price AB; Paini A; van Thriel C; Benfenati E; Ndaw S; Bessems J; Behnisch PA; Leng G; Duca RC; Verhagen H; Cubadda F; Brennan L; Ali I; David A; Mustieles V; Fernandez MF; Louro H; Pasanen-Kase R
    Environ Int; 2021 Jan; 146():106257. PubMed ID: 33395925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBM4EU feasibility studies: Lessons learned in combining health and human biomonitoring studies.
    Elonheimo HM; Uusitalo K; Moore S; Andersson AM; Baber R; Wirkner K; David M; Kolossa-Gehring M; Stewart L; Sepai O; Lermen D; Bartel-Steinbach M; Rantakokko P; Koponen J; Tolonen H
    Int J Hyg Environ Health; 2023 Mar; 248():114100. PubMed ID: 36508963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical prioritisation strategy in the European Human Biomonitoring Initiative (HBM4EU) - Development and results.
    Ougier E; Ganzleben C; Lecoq P; Bessems J; David M; Schoeters G; Lange R; Meslin M; Uhl M; Kolossa-Gehring M; Rousselle C; Vicente JL
    Int J Hyg Environ Health; 2021 Jul; 236():113778. PubMed ID: 34089975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative].
    Weise P; Apel P; Kolossa-Gehring M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Sep; 65(9):936-939. PubMed ID: 35997778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt.
    Vorkamp K; Esteban López M; Gilles L; Göen T; Govarts E; Hajeb P; Katsonouri A; Knudsen LE; Kolossa-Gehring M; Lindh C; Nübler S; Pedraza-Díaz S; Santonen T; Castaño A
    Int J Hyg Environ Health; 2023 Jun; 251():114183. PubMed ID: 37148759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizer.
    Lange R; Apel P; Rousselle C; Charles S; Sissoko F; Kolossa-Gehring M; Ougier E
    Int J Hyg Environ Health; 2021 May; 234():113722. PubMed ID: 33711757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept.
    Loh MM; Schmidt P; Christopher de Vries Y; Vogel N; Kolossa-Gehring M; Vlaanderen J; Lebret E; Luijten M
    Toxics; 2023 Apr; 11(5):. PubMed ID: 37235224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
    Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
    Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The questionnaire design process in the European Human Biomonitoring Initiative (HBM4EU).
    González-Alzaga B; Hernández AF; Kim Pack L; Iavicoli I; Tolonen H; Santonen T; Vinceti M; Filippini T; Moshammer H; Probst-Hensch N; Kolossa-Gehring M; Lacasaña M
    Environ Int; 2022 Feb; 160():107071. PubMed ID: 34979351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Mixtures in the EU Population: Composition and Potential Risks.
    Socianu S; Bopp SK; Govarts E; Gilles L; Buekers J; Kolossa-Gehring M; Backhaus T; Franco A
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitutes mimic the exposure behaviour of REACH regulated phthalates - A review of the German HBM system on the example of plasticizers.
    Lemke N; Murawski A; Lange R; Weber T; Apel P; Dębiak M; Koch HM; Kolossa-Gehring M
    Int J Hyg Environ Health; 2021 Jul; 236():113780. PubMed ID: 34126298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.